Big Pharma vs. Big Pharma in Court Battles over Biosimilar Drugs
FDA Panel Supports Novartis Biosimilar of Etanercept
FDA Staff Says Amgen Biosimilar ‘Highly Similar’ to AbbVie’s Humira
U.S. Patent Office Rules Against Amgen Humira Challenge
Amgen Files for U.S. Approval of Biosimilar
Novartis Biosimilar Takes Aim at Amgen’s Enbrel
Novartis Launches First U.S. Biosimilar Drug at 15% Discount
Teriparatide to Denosumab Switch Helpful in Osteoporosis
